Narumi Kato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Narumi Kato has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Akinori Moriichi
Department of Specific Pediatric Chronic Disease Information National Center for Child Health and Development Setagaya‐Ku, Tokyo Japan
3 shared publicationsNaho Morisaki
Department of Social Medicine National Center for Child Health and Development Setagaya‐ku Tokyo Japan
2 shared publications- Naho Morisaki
Department of Social Medicine, National Center for Child Health and Development, Tokyo, Japan
2 shared publications - Akinori Moriichi
Division of Information for Specific Pediatric Chronic Diseases, Research Institute National Center for Child Health and Development, Tokyo, Japan
1 shared publication - Erika Kuwahara
Division of Specific Pediatric Chronic Diseases, Research Institute, National Center for Child Health and Development
1 shared publication Hiroshi Tamai
Department of Pediatrics, Osaka Medical College, Osaka, Japan
1 shared publication
Latest Publications
- Open Access
Infant Feeding and Growth Patterns in Japanese Children: A Nationwide Secondary Analysis
Objectives: To examine age-specific growth patterns derived from Japanese cross-sectional data according to infants’ feeding and determine whether differences persist through preschool age. Methods: We analyzed secondary data from the 2023 National Growth Survey on Preschool Children in Japan, a single-wave nationwide cross-sectional survey. The participants were 8028 singleton, term-born, appropriate-for-gestational-age children aged 0–60 months without major health conditions. The feeding history up to 24 months was reported by parents and categorized as breastfed, formula-fed, or mixed-fed. Anthropometric measurements were obtained at a 1-month postnatal checkup or at checkups arranged for the survey, converted to standard deviation scores using Japanese references, and modeled with growth curves using the Lambda–Mu–Sigma method to summarize cross-sectional distributions by age. The feeding groups were compared at selected ages. Results: Breastfed infants were smaller in length/height and weight than formula-fed peers during the first 2 years, with the largest differences in infancy. The mean stature in the feeding groups became similar at older ages; by 60 months, standard deviation scores for stature and weight were comparable across the feeding groups. Head circumference patterns up to 36 months were not different by the feeding category. Conclusions: In Japan, early size differences by the feeding group show age-related convergence of cross-sectional group means by preschool, and head circumference patterns are similar across the groups. These findings support breastfeeding as sufficient for long-term growth without unnecessary formula supplementation.
Open AccessInfant Feeding and Growth Patterns in Japanese Children: A Nationwide Secondary Analysis
Objectives: To examine age-specific growth patterns derived from Japanese cross-sectional data according to infants’ feeding and determine whether differences persist through preschool age. Methods: We analyzed secondary data from the 2023 National Growth Survey on Preschool Children in Japan, a single-wave nationwide cross-sectional survey. The participants were 8028 singleton, term-born, appropriate-for-gestational-age children aged 0–60 months without major health conditions. The feeding history up to 24 months was reported by parents and categorized as breastfed, formula-fed, or mixed-fed. Anthropometric measurements were obtained at a 1-month postnatal checkup or at checkups arranged for the survey, converted to standard deviation scores using Japanese references, and modeled with growth curves using the Lambda–Mu–Sigma method to summarize cross-sectional distributions by age. The feeding groups were compared at selected ages. Results: Breastfed infants were smaller in length/height and weight than formula-fed peers during the first 2 years, with the largest differences in infancy. The mean stature in the feeding groups became similar at older ages; by 60 months, standard deviation scores for stature and weight were comparable across the feeding groups. Head circumference patterns up to 36 months were not different by the feeding category. Conclusions: In Japan, early size differences by the feeding group show age-related convergence of cross-sectional group means by preschool, and head circumference patterns are similar across the groups. These findings support breastfeeding as sufficient for long-term growth without unnecessary formula supplementation.
- Open Access
- 19 September 2025
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (2) , 329-338
Mortality Patterns and Phenotypic Clusters in Trisomy 13: A Population‐Based Study From Japan
Trisomy 13, the third most common autosomal trisomy after trisomy 21 and trisomy 18, is associated with a significantly high infant mortality rate. However, large‐scale studies examining causes of death in trisomy 13 remain scarce. Therefore, we aimed to better understand the mortality patterns. To this end, a population‐based study was conducted using Japanese population‐based mortality data from the Vital Statistics Database ( n = 4,230,092 death records); we examined early mortality and identified phenotypic subgroups based on combinations of co‐occurring causes of death. We identified 150 individuals with trisomy 13 who died between 2019 and 2021. Cardiovascular disease was significantly associated with early mortality. Using K ‐means clustering based on principal components of cause‐of‐death categories, we identified three distinct subgroups: respiratory‐dominant (19%), cardiovascular‐dominant (64%), and multi‐organ involvement (17%). The cardiovascular‐dominant cluster showed the highest rate of death before age 1 (83%; p = 0.001), while surgical intervention rates did not significantly differ across clusters. These findings highlight phenotypic heterogeneity and may support individualized care planning for trisomy 13 and provide insights that may support future care and decision‐making.
- 19 September 2025
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (2) , 329-338
Open AccessMortality Patterns and Phenotypic Clusters in Trisomy 13: A Population‐Based Study From Japan
Trisomy 13, the third most common autosomal trisomy after trisomy 21 and trisomy 18, is associated with a significantly high infant mortality rate. However, large‐scale studies examining causes of death in trisomy 13 remain scarce. Therefore, we aimed to better understand the mortality patterns. To this end, a population‐based study was conducted using Japanese population‐based mortality data from the Vital Statistics Database ( n = 4,230,092 death records); we examined early mortality and identified phenotypic subgroups based on combinations of co‐occurring causes of death. We identified 150 individuals with trisomy 13 who died between 2019 and 2021. Cardiovascular disease was significantly associated with early mortality. Using K ‐means clustering based on principal components of cause‐of‐death categories, we identified three distinct subgroups: respiratory‐dominant (19%), cardiovascular‐dominant (64%), and multi‐organ involvement (17%). The cardiovascular‐dominant cluster showed the highest rate of death before age 1 (83%; p = 0.001), while surgical intervention rates did not significantly differ across clusters. These findings highlight phenotypic heterogeneity and may support individualized care planning for trisomy 13 and provide insights that may support future care and decision‐making.
- Open Access
- 11 May 2024
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (9) , e63710
Trends in the survival of patients with trisomy 13 from 1995 to 2021: A population study in Japan
It remains unclear whether recent changes in the prognosis and management of patients with trisomy 13 impact patient survival. We investigated changes in survival of patients with trisomy 13 in Japan. Data from the Vital Statistics Database in Japan was retrieved to examine the association of sex, surgical history, and years of birth and death with changes in survival patterns in 1164 patients with trisomy 13 between 1995 and 2021. The rates of deaths due to trisomy 13 increased from 9.8% to 23.1% in those over 1 year of age and from 7.3% to 19.2% in those within 24 h of birth between 1995 and 2021. The median survival time was longer in 2009–2021 than in 1996–2008 (40 vs. 84 days, p < 0.001). The median survival time and the rate of patients with surgical history increased from 91 days and 16.0% in 1996–2008 to 179 days and 28.0% in 2009–2021, respectively. Median survival time among patients with trisomy 13 has increased over the last 26 years, with almost 1 in 3 patients currently surviving for more than 1 year. The increased surgical intervention rate might have contributed to this improvement.
- 11 May 2024
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (9) , e63710
Open AccessTrends in the survival of patients with trisomy 13 from 1995 to 2021: A population study in Japan
It remains unclear whether recent changes in the prognosis and management of patients with trisomy 13 impact patient survival. We investigated changes in survival of patients with trisomy 13 in Japan. Data from the Vital Statistics Database in Japan was retrieved to examine the association of sex, surgical history, and years of birth and death with changes in survival patterns in 1164 patients with trisomy 13 between 1995 and 2021. The rates of deaths due to trisomy 13 increased from 9.8% to 23.1% in those over 1 year of age and from 7.3% to 19.2% in those within 24 h of birth between 1995 and 2021. The median survival time was longer in 2009–2021 than in 1996–2008 (40 vs. 84 days, p < 0.001). The median survival time and the rate of patients with surgical history increased from 91 days and 16.0% in 1996–2008 to 179 days and 28.0% in 2009–2021, respectively. Median survival time among patients with trisomy 13 has increased over the last 26 years, with almost 1 in 3 patients currently surviving for more than 1 year. The increased surgical intervention rate might have contributed to this improvement.
- Open Access
- 7 October 2021
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (1) , 224-236
Causes of death in patients with Down syndrome in 2014–2016: A population study in Japan
Despite the higher mortality rates in patients with Down syndrome compared with the general Japanese population, the life span has dramatically increased in Japan and other countries. We aimed to clarify recent causes of death in patients with Down syndrome in Japan. We calculated proportionate mortality and standardized mortality odds ratios (SMORs) among all deaths registered with Down syndrome as the cause of death (ICD-10 code, Q90) in the Japanese National Death Registry Database in 2014–2016. In the study period, 762 in patients with Down syndrome died. The main causes of death were pneumonia/respiratory infections (20.5%), congenital malformations of the circulatory system (11.2%), other diseases of the circulatory system (9.2%), and aspiration pneumonia (8.4%). The SMORs (95% confidence intervals) were higher for natural death, defined as death of an elderly person with no other cause of death to be mentioned (55.73 [36.92–84.12]), early-onset Alzheimer's disease, defined as Alzheimer's disease with onset <65 years of age (29.36 [16.44–52.44]), aspiration pneumonia (18.33 [14.03–23.96]), pneumonia/respiratory infections (8.11 [6.76–9.73]), congenital malformations of the circulatory system (8.07 [5.98–10.88]), and leukemia/lymphoma (2.16 [1.55–2.99]) but lower for malignant solid tumors (0.04 [0.02–0.06]) in patients with Down syndrome. Patients with Down syndrome had the greatest relative risk of dying from natural death, early-onset Alzheimer's disease, and respiratory illnesses, highlighting the need for appropriate medical, health, and welfare services.
- 7 October 2021
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (1) , 224-236
Open AccessCauses of death in patients with Down syndrome in 2014–2016: A population study in Japan
Despite the higher mortality rates in patients with Down syndrome compared with the general Japanese population, the life span has dramatically increased in Japan and other countries. We aimed to clarify recent causes of death in patients with Down syndrome in Japan. We calculated proportionate mortality and standardized mortality odds ratios (SMORs) among all deaths registered with Down syndrome as the cause of death (ICD-10 code, Q90) in the Japanese National Death Registry Database in 2014–2016. In the study period, 762 in patients with Down syndrome died. The main causes of death were pneumonia/respiratory infections (20.5%), congenital malformations of the circulatory system (11.2%), other diseases of the circulatory system (9.2%), and aspiration pneumonia (8.4%). The SMORs (95% confidence intervals) were higher for natural death, defined as death of an elderly person with no other cause of death to be mentioned (55.73 [36.92–84.12]), early-onset Alzheimer's disease, defined as Alzheimer's disease with onset <65 years of age (29.36 [16.44–52.44]), aspiration pneumonia (18.33 [14.03–23.96]), pneumonia/respiratory infections (8.11 [6.76–9.73]), congenital malformations of the circulatory system (8.07 [5.98–10.88]), and leukemia/lymphoma (2.16 [1.55–2.99]) but lower for malignant solid tumors (0.04 [0.02–0.06]) in patients with Down syndrome. Patients with Down syndrome had the greatest relative risk of dying from natural death, early-onset Alzheimer's disease, and respiratory illnesses, highlighting the need for appropriate medical, health, and welfare services.
- 21 June 2020
- Published by Wiley in Pediatrics International
- Vol. 63 (1) , 94-101
Secular trends in longevity among people with Down syndrome in Japan, 1995–2016
Background: Life expectancy in Japan has increased dramatically and is one of the longest in the world. However, the changes in lifespan in Japanese individuals with congenital diseases remain unknown. We investigated secular changes in the lifespan of people with Down syndrome over the last 20 years.Methods: We observed secular trends in the number of stillbirths, deaths and the mortality rates at ages 20, 40, and 60 among all deaths registered with Down syndrome as the cause of death (ICD10 code: Q90) in the Japan national death registry database between 1995 and 2016. Changes in the median age at death between 1995–2005 and 2006–2016 were investigated based on sex and history of surgery.Results: We identified 240 stillbirths and 1,099 deaths in this period. The annual number of stillbirths and deaths above the age of 1 year increased, whereas the number of deaths below 1 year did not change. The proportional mortality indicator at ages 20, 40, and 60 increased from 21.7%, 11.7%, and 1.7% in 1995 to 69.9%, 66.7%, and 36.6% in 2016, respectively. The median age at death was higher in females, individuals without a surgical history, and deaths occurring in 2006–2016. The median age at death increased over the period in those without a surgical history.Conclusions: The age at death among people with Down syndrome has increased over the last 20 years, with currently 1 in 3 persons living over 60 years, necessitating adequate social welfare services in this aging population.
- 21 June 2020
- Published by Wiley in Pediatrics International
- Vol. 63 (1) , 94-101
Secular trends in longevity among people with Down syndrome in Japan, 1995–2016
Background: Life expectancy in Japan has increased dramatically and is one of the longest in the world. However, the changes in lifespan in Japanese individuals with congenital diseases remain unknown. We investigated secular changes in the lifespan of people with Down syndrome over the last 20 years.Methods: We observed secular trends in the number of stillbirths, deaths and the mortality rates at ages 20, 40, and 60 among all deaths registered with Down syndrome as the cause of death (ICD10 code: Q90) in the Japan national death registry database between 1995 and 2016. Changes in the median age at death between 1995–2005 and 2006–2016 were investigated based on sex and history of surgery.Results: We identified 240 stillbirths and 1,099 deaths in this period. The annual number of stillbirths and deaths above the age of 1 year increased, whereas the number of deaths below 1 year did not change. The proportional mortality indicator at ages 20, 40, and 60 increased from 21.7%, 11.7%, and 1.7% in 1995 to 69.9%, 66.7%, and 36.6% in 2016, respectively. The median age at death was higher in females, individuals without a surgical history, and deaths occurring in 2006–2016. The median age at death increased over the period in those without a surgical history.Conclusions: The age at death among people with Down syndrome has increased over the last 20 years, with currently 1 in 3 persons living over 60 years, necessitating adequate social welfare services in this aging population.